Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. …

This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide, accounting for
about 9.6 million new cases and 1.5 million deaths annually. The poorest and socially …

Background The widespread use of antibiotics plays a major role in the development and
spread of antimicrobial resistance. However, important knowledge gaps still exist regarding …

Tuberculosis (TB) is a major public health concern worldwide: despite a regular, although
slow, decline in incidence over the last decade, as many as 8.6 million new cases and 1.3 …

Introduction Rising rates of antimicrobial resistance (AMR) globally continue to pose agrave
threat to human health. Low- and middle-income countries (LMICs) are disproportionately …

Background We assessed the impact of the coronavirus disease 2019 (COVID-19) epidemic
in India on the consumption of antibiotics and hydroxychloroquine (HCQ) in the private …

Background Infectious diseases still represent an important cause of morbidity and mortality
among foreign-born individuals. The rising migration flows towards Europe throughout the …

Background Antibiotic use drives antibiotic resistance. Objectives To systematically review
the literature and estimate associations between prior exposure to antibiotics across World …

No large study has ever evaluated the efficacy, safety and tolerability of meropenem/clavulanate
to treat multidrug- and extensively drug-resistant tuberculosis (MDR- and XDR-TB). The …